Analysis of the efficacy and safety of sildenafil citrate in the geriatric population

BJU International

Volumn 100, Issue 1, 2007, Pages 117-121

  Müller, Alexander ^a,b   Smith, Lizette ^a   Parker, Marilyn ^c   Mulhall, John P ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Efficacy; Geriatric population; Phosphodiesterase inhibitor; Safety; Sildenafil citrate

Indexed keywords

SILDENAFIL;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CARDIOVASCULAR SYMPTOM; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; FLUSHING; GERIATRIC PATIENT; HEARTBURN; HUMAN; HYPERTENSION; LIFE EXPECTANCY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REFERENCE DATABASE; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VISION;

AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; DATABASES; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; QUESTIONNAIRES; RISK FACTORS; SULFONES; TREATMENT OUTCOME;

EID: 34249931429     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06915.x     Document Type: Article

References (25)

1. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinmann KP, McKinlay JB. Incidence of erectile dysfunction in men 40-69 years old: longitudinal results form the Massachusetts Male Aging Study. J Urol 2000 163 : 460 3
2. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000 12 (Suppl. 4 S6 S11
3. National Center for Health Statistics, DHSS 1989
4. Shiri R, Koskimaki J, Hakkinen J et al. Tampere Ageing Male Urological Study. Effects of age, comorbidity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS). Eur Urol 2004 45 : 628 33
5. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994 151 : 54 61
6. Pfizer Inc. VIAGRA® (Sildenafil Citrate). Product Description : New York, NY, USA : 10017, Pfizer Laboratories, Division of Pfizer Inc., 2007
7. Masumori N, Tsukamoto T, Kumamoto Y et al. Decline of sexual function with age in Japanese men compared with American men - results of two community-based studies. Urology 1999 54 : 335 45
8. Marumo K, Nakashima J, Murai M. Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol 2001 8 : 53 9
9. Blanker MH, Bosch JL, Groeneveld FP et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50-78 years old: prevalence, concern, and relation to sexual activity. Urology 2001 57 : 763 8
10. Chew KK, Earle CM, Stuckey BG, Jamrozik K, Keogh EJ. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res 2000 12 : 41 5
11. Monga M, Bettencourt R, Barrett-Connor E. Community-based study of erectile dysfunction and sildenafil use: the Rancho Bernardo Study. Urology 2002 59 : 753 7
12. Pinnock C, O'Brien B, Marshall VR. Older men's concerns about their urological health: a qualitative study. Aust NZ J Public Health 1998 22 (Suppl. 368 73
13. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998 338 : 1397 404
14. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group JAMA 1999 281 : 421 6
15. Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol 1999 83 : 29C 34C
16. Kloner RA, Brown M, Prisant LM, Collins M. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertens 2001 14 : 70 3
17. Steers W, Guay AT, Leriche A et al. Assessment of the efficacy and safety of Viagra (sildenafil citrate) in men with erectile dysfunction during long-term treatment. Int J Impot Res 2001 13 : 261 7
18. Fujisawa M, Sawada K. Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction. Arch Androl 2004 50 : 255 60
19. Hartmann U, Meuleman EJ, Cuzin B et al. Sildenafil citrate (Viagra): analysis of preferred doses in a European, six-month, double-blind, placebo-controlled, flexible dose escalation study in patients with erectile dysfunction. Int J Clin Pract Suppl 1999 102 : 27 9
20. Tsujimura A, Yamanaka M, Takahashi T et al. The clinical studies of sildenafil for the ageing male. Int J Androl 2002 25 : 28 33
21. Wagner G, Montorsi F, Auerbach S, Collins M. Sildenafil citrate (VIAGRA) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis. J Gerontol A Biol Sci Med Sci 2001 56 : M113 9
22. Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res 1998 10 : 69 74
23. Benchekroun A, Faik M, Benjelloun S, Bennani S, El Mrini M, Smires A. A baseline-controlled, open-label, flexible dose-escalation study to assess the safety and efficacy of sildenafil citrate (Viagra) in patients with erectile dysfunction. Int J Impot Res 2003 15 (Suppl. 1 S19 24
24. Meuleman E, Cuzin B, Opsomer RJ et al. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction. BJU Int 2001 87 : 75 81
25. Montague DK, Barada JH, Bleker AM et al. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urological Association. J Urol 1996 156 : 2007 11